VALNEVA
Declaration of shares and voting rights
Status on December 31, 2022 (corrected data) and January 4, 2023
__________________________________________________________________________________________
Company name: VALNEVA
Registered office: 6 rue Alain Bombard, 44800 Saint-Herblain (France)
Regulated market of Euronext Paris – Compartment A
Declaration date: January 19, 2023
Erratum: status on December 31, 2022
| Number of shares composing the share capital of Valneva |
Total number of voting rights including suspended voting rights* | Description of the change | Date on which this change was recognized | Total number of voting rights excluding suspended voting rights** |
|
138,367,482
including:
|
160,933,882 | Exercise of 12,500 BSA equity warrant
Double voting rights granted on 9,775 ordinary shares |
December 1st, 8 & 10, 2022
December 7, 9, 16 & 23, 2022 |
160,809,560 |
Interim status on January 4, 2023
| Number of shares composing the share capital of Valneva |
Total number of voting rights including suspended voting rights* | Description of the change | Date on which this change was recognized | Total number of voting rights excluding suspended voting rights** |
|
138,346,968 ordinary shares with a par value of €0.15 each |
160,933,882 | Cancellation of 20,514 preferred shares convertible into ordinary shares, with a par value of €0.15 each | January 4, 2023 i | 160,809,560 |
i Management Board decisions of January 4, 2023.
___________________________
* Theoretical voting rights. This number is used as the basis for calculating threshold crossings. In accordance with Article 223-11 of the AMF General Regulations, this number is calculated on the basis of all shares to which voting rights are attached, including those for which voting rights have been suspended.
** Net (or exercisable at a General Meeting) voting rights.
Attachment
Strategic Expansion into Cardio AI-Driven Healthcare SolutionsCollaboration to Enhance Patient-Centered Digital Healthcare TechnologiesWelcomes Key Industry…
Charlotte, North Carolina--(Newsfile Corp. - December 23, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE…
AUSTIN, TEXAS / ACCESSWIRE / December 23, 2024 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or…
Originally published in Quest Diagnostics' 2023 Corporate Responsibility ReportNORTHAMPTON, MA / ACCESSWIRE / December 23,…
Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…
WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…